Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005706 · ClinicalTrials.gov registry record · NA
Sirolimus Conversions in African-American Renal Transplant Recipients
A NA study of Absence; Kidney, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01005706: Completed NA study of Absence; Kidney, sponsored by Medical University of South Carolina.
NCT01005706 is a NA study of Absence; Kidney that has completed, run by Medical University of South Carolina. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01005706, a NA study of Absence; Kidney, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's focus is to compare the level effectiveness and safety of regimens involving Sirolimus, Cellcept and steroid to Prograf, Sirolimus and steroid in African-American recipients of kidney transplants.
Primary Outcome
Number of Participants with Kidney Rejections
Conditions Studied
Interventions
- DRUG rapamune, mycophenolate mofetil and steroid
- DRUG tacrolimus, sirolimus and steroid
Study Locations (1)
South Carolina
- The Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01005706 record still lists
NCT01005706 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Absence; Kidney appearing as the primary indexed condition, and to 2 interventions - of which rapamune, mycophenolate mofetil and steroid is the first listed.
NCT01005706 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT01005706 about?
NCT01005706 is a clinical study titled "Sirolimus Conversions in African-American Renal Transplant Recipients". This study's focus is to compare the level effectiveness and safety of regimens involving Sirolimus, Cellcept and steroid to Prograf, Sirolimus and steroid in African-American recipients of kidney transplants.
What is the current status of trial NCT01005706?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-08. Estimated completion is 2014-07.
What conditions does trial NCT01005706 study?
This clinical trial studies the following conditions: Absence; Kidney.
What interventions are being tested in trial NCT01005706?
The interventions under investigation include: rapamune, mycophenolate mofetil and steroid (DRUG), tacrolimus, sirolimus and steroid (DRUG).
Who is sponsoring clinical trial NCT01005706?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01005706 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01005706's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia